Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

Personalised Treatment in Advanced ALK + NSCLC: Applying the Science of Targeted Therapy Now and in the Future (U)

Sat 26 Sept / 13:00 - 14:30 / Hall C3

This satellite symposium is an educational program that discusses the implications and management of the EML4-ALK fusion oncogene in a subset of patients with advanced NSCLC, describes ALK-inhibitors in the clinical management of patients with ALK+ NSCLC, including patients with brain metastases, and utilizes patient case studies to understand the multi-disciplinary approach to the clinical management of advanced ALK+ NSCLC. Emerging oncogene targets and promising future treatment options are also discussed.

This Webcast and Webcast Report were supported by Novartis Oncology, all items are subject to independent peer and editorial review.


Presentations

Search this site

Search form

E-Alert

Register to our E-Alert to stay informed of new clinical research and cases published on this platform.

Share